查看所有供应商和价格请点击：
| 中文名 | 3-溴-4-氯吡啶 |
|---|---|
| 英文名 | 3-Bromo-4-chloropyridine |
| 英文别名 |
3-BroMo-4-chloridepyridine
3-Brom-4-chlor-pyridin 3-bromo-4-chloro-pyridine 4-Chlor-3-brom-pyridin MFCD00234008 4-CHLORO-3-BROMOPYRIDINE 3-bromo-2-chloro-pyridine 5-bromo-4-chloropyridine 3-BroMo-4-chloropyridine 1GR 3-Bromo-2-chloropyridine Pyridine, 3-bromo-4-chloro- bromo-3 chloro-4 pyridine 3-Bromo-4-chloropyridine Pyridine, 3-bromo-2-chloro- |
| 密度 | 1.7±0.1 g/cm3 |
|---|---|
| 沸点 | 207.3±20.0 °C at 760 mmHg |
| 分子式 | C5H3BrClN |
| 分子量 | 192.441 |
| 闪点 | 79.2±21.8 °C |
| 精确质量 | 190.913727 |
| PSA | 12.89000 |
| LogP | 2.11 |
| 外观性状 | 淡黄色针状 |
| 蒸汽压 | 0.3±0.4 mmHg at 25°C |
| 折射率 | 1.581 |
| 储存条件 | 密闭于阴凉干燥环境中 |
| 稳定性 | 遵照规定使用和储存则不会分解。 |
| 分子结构 | 1、 摩尔折射率：36.92 2、 摩尔体积（m3/mol）：110.7 3、 等张比容（90.2K）：287.7 4、 表面张力（dyne/cm）：45.4 5、 极化率（10 -24cm 3）：14.63 |
| 计算化学 | 1.疏水参数计算参考值（XlogP）:2.2 2.氢键供体数量:0 3.氢键受体数量:1 4.可旋转化学键数量:0 5.互变异构体数量:无 6.拓扑分子极性表面积12.9 7.重原子数量:8 8.表面电荷:0 9.复杂度:78.8 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
| 更多 | 1. 性状：淡黄色液体 2. 密度（g/mL,25/4℃）：无可用 3. 相对蒸汽密度（g/mL,空气=1）：无可用 4. 熔点（ºC）：无可用 5. 沸点（ºC,常压）：无可用 6. 沸点（ºC,5.2kPa）：无可用 7. 折射率：无可用 8. 闪点（ºC）：无可用 9. 比旋光度（º）：无可用 10. 自燃点或引燃温度（ºC）：无可用 11. 蒸气压（kPa,25ºC）：无可用 12. 饱和蒸气压（kPa,60ºC）：无可用 13. 燃烧热（KJ/mol）：无可用 14. 临界温度（ºC）：无可用 15. 临界压力（KPa）：无可用 16. 油水（辛醇/水）分配系数的对数值：无可用 17. 爆炸上限（%,V/V）：无可用 18. 爆炸下限（%,V/V）：无可用 19. 溶解性：无可用 |
Synonym: Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: 20/22 36/37/38 Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Irritating to eyes, respiratory system and skin. Potential Health Effects Eye: Causes eye irritation. Skin: Causes skin irritation. May be harmful if absorbed through the skin. Ingestion: Harmful if swallowed. May cause irritation of the digestive tract. Inhalation: Harmful if inhaled. Causes respiratory tract irritation. Chronic: Not available. Section 4 - FIRST AID MEASURES Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Ingestion: Get medical aid. Wash mouth out with water. Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Notes to Physician: Treat symptomatically and supportively. Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Extinguishing Media: Use water spray, dry chemical, carbon dioxide, or chemical foam. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Section 7 - HANDLING and STORAGE Handling: Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes. Storage: Store in a cool, dry place. Store in a tightly closed container. Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 36953-42-1: Personal Protective Equipment Eyes: Not available. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Powder Color: off-white Odor: Not available. pH: Not available. Vapor Pressure: Not available. Viscosity: Not available. Boiling Point: Not available. Freezing/Melting Point: Not available. Autoignition Temperature: Not available. Flash Point: Not available. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: Solubility in water: Specific Gravity/Density: Molecular Formula: C5H3BrClN Molecular Weight: 192.44 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Stable under normal temperatures and pressures. Conditions to Avoid: Incompatible materials. Incompatibilities with Other Materials: Strong oxidizing agents, acids, acid chlorides, acid anhydrides. Hazardous Decomposition Products: Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide, hydrogen bromide. Hazardous Polymerization: Will not occur. Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 36953-42-1 unlisted. LD50/LC50: Not available. Carcinogenicity: 3-Bromo-4-chloropyridine - Not listed by ACGIH, IARC, or NTP. Section 12 - ECOLOGICAL INFORMATION Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA Not regulated as a hazardous material. IMO Not regulated as a hazardous material. RID/ADR Not regulated as a hazardous material. Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: XN Risk Phrases: R 20/22 Harmful by inhalation and if swallowed. R 36/37/38 Irritating to eyes, respiratory system and skin. Safety Phrases: S 22 Do not breathe dust. S 26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S 36/37/39 Wear suitable protective clothing, gloves and eye/face protection. WGK (Water Danger/Protection) CAS# 36953-42-1: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 36953-42-1 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 36953-42-1 is not listed on the TSCA inventory. It is for research and development use only. SECTION 16 - ADDITIONAL INFORMATION N/A |
|
生态学数据: 该物质对环境可能有危害，对水体应给予特别注意。
|
| 危害码 (欧洲) | Xn:Harmful; |
|---|---|
| 风险声明 (欧洲) | R20/22;R36/37/38 |
| 安全声明 (欧洲) | S22-S26-S36/37/39 |
| 海关编码 | 2933399090 |
|
~96%
36953-42-1 |
| 文献：Betschmann, Patrick; Burchat, Andrew F.; Calderwood, David J.; Curtin, Michael L.; Davidsen, Steven K.; Davis, Heather M.; Frey, Robin R.; Heyman, Howard R.; Hirst, Gavin C.; Hrnciar, Peter; Michaelides, Michael R.; Muckey, Melanie A.; Rafferty, Paul; Wada, Carol K. Patent: US2005/26944 A1, 2005 ; |
|
~10%
36953-42-1 |
| 文献：Trecourt, Francois; Breton, Gilles; Bonnet, Veronique; Mongin, Florence; Marsais, Francis; Queguiner, Guy Tetrahedron, 2000 , vol. 56, # 10 p. 1349 - 1360 |
|
~77%
36953-42-1 |
| 文献：Trecourt, Francois; Queguiner, Guy Journal of Chemical Research, Miniprint, 1982 , # 3 p. 912 - 942 |
|
~%
36953-42-1 |
| 文献：Trecourt, Francois; Queguiner, Guy Journal of Chemical Research, Miniprint, 1982 , # 3 p. 912 - 942 |
|
~%
36953-42-1 |
| 文献：Trecourt, Francois; Queguiner, Guy Journal of Chemical Research, Miniprint, 1982 , # 3 p. 912 - 942 |
|
~%
36953-42-1 |
| 文献：Trecourt, Francois; Queguiner, Guy Journal of Chemical Research, Miniprint, 1982 , # 3 p. 912 - 942 |
|
~%
36953-42-1 |
| 文献：Yamanaka, Hiroshi; Araki, Tomio; Sakamoto, Takao Chemical and Pharmaceutical Bulletin, 1988 , vol. 36, p. 2244 - 2247 |
|
~%
36953-42-1 |
| 文献：Belen'kii, L. I.; Poddubnyi, I. S.; Krayushin, M. M. Chemistry of Heterocyclic Compounds (New York, NY, United States), 1995 , vol. 31, # 6 p. 726 - 736 Khimiya Geterotsiklicheskikh Soedinenii, 1995 , # 6 p. 830 - 842 |
|
~%
详细
|
| 文献：den Hertog; Boelrijk Recueil des Travaux Chimiques des Pays-Bas, 1951 , vol. 70, p. 578 |
| 上游产品 7 | |
|---|---|
| 下游产品 4 | |
| 海关编码 | 2933399090 |
|---|---|
| 中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期 |
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
